Business ❯ Pharmaceutical Industry

Investment

Manufacturing Research and Development Market Trends Market Dynamics UK Market Market Conditions AstraZeneca Corporate Governance Sector Investment in Mexico Corporate Investment Manufacturing Facilities Merck UK Economy Foreign Investment Corporate Decisions Health Products NHS Spending Foreign Direct Investment Stock Market Pfizer Supply Chains Market Agreements U.S. Market Capital Expenditure U.S. Manufacturing Life Sciences Production Facilities Sanofi Market Opportunities Bristol Myers Squibb Healthcare Spending US Pharma Firms Research Funding International Trade

AbbVie Strikes Trump Drug-Pricing Deal, Pledges $100 Billion, Wins 3-Year Tariff Reprieve

Opaque terms leave the real savings for patients, including Medicaid enrollees, uncertain.

U.S. and U.K. Seal Three-Year Zero‑Tariff Pharma Deal Tied to Higher NHS Drug Prices

Trump Jokes About COVID After RFK Jr. Coughs at Oval Office Pfizer Event

GSK Pledges $30 Billion U.S. Investment as UK Drug-Pricing Standoff Drives Pullbacks

BMS, BioNTech Small-Cell Lung Cancer Drug Posts 76% Tumor Reduction, Advances to Phase III

AstraZeneca Pauses £200m Cambridge Plan as Merck Axes £1bn London Hub

FDA Launches PreCheck to Accelerate U.S. Drug Manufacturing Approvals